Pancreatic Cancer Vaccine Trial Enrolling Patients in Cincinnati – Potential Game Changer for Cancer Treatment!
CINCINNATI, OHIO – The University of Cincinnati Cancer Center has initiated the enrollment of patients in a new clinical trial that focuses on testing a vaccine for the treatment of pancreatic cancer. This Phase 2 trial is groundbreaking as it marks the first site in the Midwest to begin enrolling patients for the study. Pancreatic cancer is a devastating disease, with over 66,000 Americans expected to be diagnosed this year alone. It ranks as the …